Ergo Science (Ergo Science) Interest Expense : $0.00 Mil (TTM As of Sep. 2006)

View and export this data going back to . Start your Free Trial

What is Ergo Science Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ergo Science's interest expense for the three months ended in Sep. 2006 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2006 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ergo Science's Operating Income for the three months ended in Sep. 2006 was $ -0.12 Mil. Ergo Science's Interest Expense for the three months ended in Sep. 2006 was $ 0.00 Mil. Ergo Science has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Ergo Science Interest Expense Historical Data

The historical data trend for Ergo Science's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ergo Science Interest Expense Chart

Ergo Science Annual Data

Trend

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Interest Expense

Get a 7-Day Free Trial

Ergo Science Quarterly Data
	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Ergo Science Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2006 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Ergo Science (GREY:ERGN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ergo Science's Interest Expense for the three months ended in Sep. 2006 was $0.00 Mil. Its Operating Income for the three months ended in Sep. 2006 was $-0.12 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2006 was $0.00 Mil.

Ergo Science's Interest Coverage for the quarter that ended in Sep. 2006 is calculated as

Ergo Science had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Ergo Science (Ergo Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Ergo Science Corp (GREY:ERGN) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

402 Office Park Drive, Suite 260, Birmingham, AL, USA, 35223

Website

http://www.ergoscience.com

Ergo Science Corp is a United States based workforce injury prevention and treatment provider. It is focused on employee safety and employer risk reduction. The company offers physical abilities tests built from defensible, peer-reviewed research; evidence-based injury prevention and rehabilitation for diversified businesses.

Executives

Citigroup Inc	director	388 GREENWICH STREET, NEW YORK NY 10013
Iticorp	director	399 PARK AVENUE, NEW YORK NY 10043
Citicorp Banking Corp	director	ONE PENNS WAY, NEW CASTLE DE 19720
Citigroup Holdings Co	director	336 THE STRAND, LONDON ENGLAND
Court Square Capital Ltd	director	399 PARK AVE, NEW YORK NY 10043

Ergo Science (Ergo Science) Headlines

No Headlines